News
Starting on a weight loss medication has helped Joie Armstrong prioritize caring for herself, including finding more ...
Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.
Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...
Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...
Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...
FROM eggy burps to stomach-churning nausea, there appears to be an endless list of side effects linked to Ozempic-like jabs. But now, experts are getting candid on a fat jab complication that ...
3d
Investor's Business Daily on MSNMcDonald's Stock Bitten By Big Downgrade Over Weight-Loss DrugsMcDonald's stock was cut from buy to sell over a potential double-digit loss in sales due to weight-loss drugs.
A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...
Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...
Body image is part physical and part mental. If weight loss alone isn't helping, strategies from body image psychology can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results